Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Deferred Taxes (2020 - 2022)

BioCorRx's Deferred Taxes history spans 3 years, with the latest figure at -$28829.0 for Q1 2022.

  • For Q1 2022, Deferred Taxes fell 12.78% year-over-year to -$28829.0; the TTM value through Mar 2022 reached -$109556.0, down 20.63%, while the annual FY2021 figure was -$106290.0, 26.85% down from the prior year.
  • Deferred Taxes for Q1 2022 was -$28829.0 at BioCorRx, down from -$27969.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at -$18534.0 in Q1 2020 and bottomed at -$28829.0 in Q1 2022.
  • The 3-year median for Deferred Taxes is -$25563.0 (2021), against an average of -$24323.2.
  • The largest annual shift saw Deferred Taxes plummeted 37.93% in 2021 before it decreased 12.78% in 2022.
  • A 3-year view of Deferred Taxes shows it stood at -$24775.0 in 2020, then fell by 12.89% to -$27969.0 in 2021, then decreased by 3.07% to -$28829.0 in 2022.
  • Per Business Quant, the three most recent readings for BICX's Deferred Taxes are -$28829.0 (Q1 2022), -$27969.0 (Q4 2021), and -$26680.0 (Q3 2021).